5 Stomach Cancer Clinical Trials in Houston, TX (2026)

Q: How do I join a clinical trial in Houston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you.

Recruiting Stomach Cancer Studies in Houston

NCT05482893Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

This is a first-in-human, Phase 1/2, open-label, dose escalation and dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and prelimi...

Houston, TXPHASE1350 participantsPhanes Therapeutics

View Study Details

NCT03161522Recruiting

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

This phase II trial studies how well chemotherapy with or without radiation or surgery works in treating participants with esophageal or gastric cancer that has spread to less than 3 places in the bod...

Houston, TXPHASE2100 participantsM.D. Anderson Cancer Center

View Study Details

NCT06364410Recruiting

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

This phase I trial tests the safety, side effects, and best dose of azenosertib in combination with trastuzumab deruxtecan in treating patients with HER2-positive gastric or gastroesophageal junction ...

Houston, TXPHASE148 participantsNational Cancer Institute (NCI)

View Study Details

NCT05977998Recruiting

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer....

Houston, TXPHASE230 participantsM.D. Anderson Cancer Center

View Study Details

NCT07509008Recruiting

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

The goal of this clinical research study is to study the recommended dose of TROP2 CAR/IL-15 TGFBR2 KO NK cells that can be given intraperitoneally (infused directly into the stomach area) to particip...

Houston, TXPHASE110 participantsM.D. Anderson Cancer Center

View Study Details

About Stomach Cancer Clinical Trials in Houston

Stomach (gastric) cancer develops in the lining of the stomach and is more common in certain regions of the world. Risk factors include H. pylori infection, smoking, and diet. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.

There are currently 5 stomach cancer clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 538 participants. Research is being sponsored by Phanes Therapeutics, M.D. Anderson Cancer Center, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Stomach Cancer Clinical Trials in Houston — FAQ

Are there stomach cancer clinical trials in Houston?

Yes, there are 5 stomach cancer clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What stomach cancer treatments are being tested?

The 5 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for stomach cancer.

Data updated October 12, 2026 from ClinicalTrials.gov